Patents matching “treatment”

US 7183389

Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)

Molecular Discoveries, Inc. · Granted Feb 27, 2007 · Expires Feb 22, 2027

US 7183065

Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens

The Regents of the University of California · Granted Feb 27, 2007 · Expires Feb 22, 2027

US 7179888

Antigenic, non-toxic mutants of Clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith

The Board of Regents of the University of Oklahoma · Granted Feb 20, 2007 · Expires Feb 15, 2027

US 7175838

Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state

The United States of America represented by the Department of Health and Human Services · Granted Feb 13, 2007 · Expires Feb 8, 2027

US 7169594

Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 30, 2007 · Expires Jan 25, 2027

US 7163678

Reovirus for the treatment of ral-mediated cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Jan 16, 2007 · Expires Jan 11, 2027

US 7153866

Use of tempol for the treatment of Li-Fraumeni syndrome and ataxia telangiectasia

The United States of America, as represented by the Department of Health and Human Services · Granted Dec 26, 2006 · Expires Dec 21, 2026

US 7151100

Indole compounds useful for the treatment of cancer

The Regents of the University of California · Granted Dec 19, 2006 · Expires Dec 14, 2026

US 7150871

Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6

The Regents of the University of California · Granted Dec 19, 2006 · Expires Dec 14, 2026

US 7148201

Use of human plasma hyaluronidase in cancer treatment

The Regents of the University of California · Granted Dec 12, 2006 · Expires Dec 7, 2026

US 7141553

A3AR agonists for the treatment of inflammatory arthritis

Can-Fite Biopharma Ltd. Israel · Granted Nov 28, 2006 · Expires Nov 23, 2026

US 7138237

Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen

The Regents of the University of California · Granted Nov 21, 2006 · Expires Nov 16, 2026

US 7135490

Method for the treatment of glomerulonephritis

Takeda Pharmaceutical Company Limited · Granted Nov 14, 2006 · Expires Nov 9, 2026

US 7125541

Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy

THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS · Granted Oct 24, 2006 · Expires Oct 19, 2026

US 7122579

Eye treatments using synthetic thyroid hormone compositions

The Regents of the University of California · Granted Oct 17, 2006 · Expires Oct 12, 2026

US 7115262

Chimeric protein for prevention and treatment of HIV infection

The United States of America, as represented by the Department of Health and Human Services · Granted Oct 3, 2006 · Expires Sep 28, 2026

US 7112317

Combined methods and compositions for tumor vasculature targeting and tumor treatment

The Board of Regents of the University of Texas System · Granted Sep 26, 2006 · Expires Sep 21, 2026

US 7105561

Use of etodolac for the treatment of prostate cancer

The Regents of the University of California · Granted Sep 12, 2006 · Expires Sep 7, 2026

US 7105560

Use of etodolac in the treatment of multiple myeloma

The Regents of the University of California · Granted Sep 12, 2006 · Expires Sep 7, 2026

US 7105171

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

The Regents of the University of California · Granted Sep 12, 2006 · Expires Sep 7, 2026

US 7105183

Chlorite in the treatment of neurodegenerative disease

The Regents of the University of California · Granted Sep 12, 2006 · Expires Sep 7, 2026

US 7101852

Composition and method for treatment and prevention of restenosis

The Board of Regents of the University of Texas System · Granted Sep 5, 2006 · Expires Aug 31, 2026

US 7101557

Combined tissue factor methods for coagulation and tumor treatment

The Board of Regents of the University of Texas System · Granted Sep 5, 2006 · Expires Aug 31, 2026

US 7101547

Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 5, 2006 · Expires Aug 31, 2026